Takeda Dodges Doc Destruction Claims In Wis. Actos Suit
Takeda Pharmaceuticals America Inc. deflected document destruction claims from an upcoming trial in Wisconsin state court over the alleged bladder cancer risks of its diabetes drug Actos, when a judge found...To view the full article, register now.
Already a subscriber? Click here to view full article